Showing 2601-2610 of 3039 results for "".
- Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the UShttps://modernod.com/news/alcon-announces-broad-retail-availability-of-pataday-once-daily-relief-extra-strength-in-the-u-s/2478886/Alcon announced that Pataday Once Daily Relief Extra Strength is now available in-store and online at U.S. retailers following its 2020 approval by the FDA for sale over the counter (OTC). As Alcon’s third Rx-to-OTC switch in the past 12 months, Pataday Once Daily Relief Extra Strength (o
- LumiThera Completes Patient Enrollment in LIGHTSITE III Clinical Study to Treat Dry AMDhttps://modernod.com/news/lumithera-completes-patient-enrollment-in-the-lightsite-iii-clinical-study-to-treat-dry-amd/2478882/LumiThera announced it has completed enrollment in its multicenter US clinical study in non-neovascular (dry) age-related macular degeneration (AMD) patients. The randomized, multicenter study, LIGHTSITE III, enrolled the last patient at the Byers Eye Insti
- Clearside Biomedical Announces CLS-AX Presentation Delivered at Angiogenesis, Exudation, and Degeneration 2021 Programhttps://modernod.com/news/clearside-biomedical-announces-cls-ax-presentation-delivered-at-angiogenesis-exudation-and-degeneration-2021-program/2478874/Clearside Biomedical announced that David M. Brown, MD, delivered a presentation entitled, “Axitinib: A Novel TKI Delivered by Suprachoroidal Injection for AMD” at the virtual Angiogenesis, Exudation, and Degeneration 2021 program hosted by the University of Miami Health System Ba
- 2021 ASCRS Annual Meeting Moved to Las Vegas in Julyhttps://modernod.com/news/2021-ascrs-annual-meeting-moved-to-las-vegas-in-july/2478825/The American Society of Cataract and Refractive Surgery (ASCRS) announced that the 2021 ASCRS Annual Meeting, previously scheduled to take place in San Francisco in August, is now scheduled to be held July 23–27 in Las Vegas, Nevada, at the Mandalay Bay Convention Center. “Due to the
- Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Wet AMDhttps://modernod.com/news/prevent-blindness-and-bausch-lomb-to-launch-year-long-video-series-to-raise-awareness-of-wet-amd/2478818/Bausch + Lomb and Prevent Blindness, the nation’s oldest volunteer eye health non-profit organization, announced they are joining together for the sixth consecutive year during AMD Awareness Month to raise awareness of age-related macular degeneration (AMD). The two organizations will launch a ye
- Neurophth Therapeutics Appoints Qiutang Li, PhD, as Chief Scientific Officerhttps://modernod.com/news/neurophth-therapeutics-appoints-qiutang-li-phd-as-chief-scientific-officer/2478800/Wuhan Neurophth Biotechnology, a developer of AAV-delivered gene therapies for the treatment of ocular diseases, announced the appointment of Qiutang Li, PhD, as Chief Scientific Officer. She will be mainly responsible for the company’s global R&D, IND portfolio strategy, and the establ
- DORC Announces Health Canada Approval of Tissueblue for Staining of the ILM During Vitreoretinal Surgeryhttps://modernod.com/news/dorc-announces-health-canada-approval-of-tissueblue-for-staining-of-the-ilm-during-vitreoretinal-surgery/2478799/DORC has announced that it has received notification from Health Canada that the application for Tissueblue (Brilliant Blue G Ophthalmic Solution 0.025%) has been approved and will be available later in 2021 via Innovamed, DORC’s local distributor partner. Tissueblue is the first dye approved by
- CVP Welcomes Three New Ophthalmology Partner Practiceshttps://modernod.com/news/cvp-welcomes-three-new-ophthalmology-partner-practices/2478760/CVP has expanded its platform in the Midwest and Mid-Atlantic regions by adding three partner practices: Columbus Ophthalmology Associates (COA), Valley Eye Institute, near Dayton, Ohio; and Virginia Beach Eye Center. CVP now includes a network of nine partner pra
- EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 Vaccinehttps://modernod.com/news/ema-receives-conditional-marketing-request-for-astrazenecas-covid-19-vaccine/2478752/The European Medicines Agency announced Tuesday that it received an application for conditional marketing authorization of AstraZeneca and the University of Oxford’s COVID-19 vaccine AZD1222. The regulator noted that the vaccine will be reviewed under an accelerated timeline with an opinion
- EyeSouth Partners Expands Network to Include 28 Doctors in Ohio and Kentucky Through Affiliation with Midwest Eye Centerhttps://modernod.com/news/eyesouth-partners-expands-network-to-include-28-doctors-in-ohio-and-kentucky-through-affiliation-with-midwest-eye-center/2478742/EyeSouth Partners has announced that it has completed an affiliation with Midwest Eye Center (MWEC), representing EyeSouth’s first in the states of Ohio and Kentucky. Terms of the deal were not disclosed. Midwest Eye Center is led by Drs. Mark Cepela, Jean Noll, Faiz Khaja, Saif Jaw